Moichor Analysis: $125K Raised
What is Moichor?
Moichor provides AI-assisted veterinary diagnostics, enabling rapid hematology and cytology evaluations for improved patient outcomes in veterinary clinics.
Employees
29
Founded
2019
Revenue
$2.5-3.5M
Business Model
Subscription-based model with revenue from diagnostic services and funding rounds.
Product Features & Capabilities
- AI-assisted hematology and cytology system, preliminary results in 15 minutes, pathologist-level results, CBC and cytology evaluation for any species, early disease detection, improve ROI with in-house diagnostics.
How much Moichor raised
1 - $125K
2021Lead Investor: Y Combinator
Competitors Overview
Moichor's main competitors in the veterinary diagnostics market include:
- Eskulap: A pharmaceutical company specializing in veterinary medicine, founded in 1991. It is based in Gliwice, Poland, and has a workforce of 57 employees. Eskulap focuses on pharmaceuticals rather than diagnostics.
2
Investors
- Y Combinator
- Neotribe Ventures
- Andrew Lockhart
- Ben Franklin Technology Partners of Central and Southern New Jersey
Market Focus
Moichor primarily focuses on the veterinary diagnostics industry, specifically providing AI-assisted solutions for hematology and cytology evaluations in veterinary clinics.
See something that needs updating? Suggest edits to this profile.